Fluvoxamine + Pomalidomide Interaction
Majorinteraction on record
Description
Strong CYP1A2 inhibitor that increased pomalidomide Cmax by 24% and AUC by 125%, increasing risk of exposure-related toxicities. Avoid concomitant use; if unavoidable, reduce pomalidomide dose.
Mechanism
CYP1A2 inhibition
Source: NLP:pomalidomide